{
    "info": {
        "nct_id": "NCT05311527",
        "official_title": "Using UroLift System With Stereotactic Ablative Body Radiotherapy For Men With Prostate Cancer and Benign Prostatic Hyperplasia (BPH): a Phase I Safety Trial",
        "inclusion_criteria": "* AJCC 8th edition clinical stage T1 (a, b, or c) or T2 (a, b, or c) adenocarcinoma of the prostate gland, Gleason 3+3 = 6 or 3+4 = 7, with no direct evidence of regional or distant metastases following appropriate staging studies. See Appendix I for details on AJCC 8th Edition staging criteria. T-staging may be assessed by multi-parametric imaging alone if digital rectal examination was deferred\n* Histologic confirmation of prostate cancer is required by biopsy performed within 18 months of registration.\n* Age ≥ 45 years.\n* Eastern Cooperative Oncology Group (ECOG) Performance status 0-1.\n* American Society of Anesthesia (ASA) physical status score of 1-3\n* Baseline AUA symptom score ≥ 17 regardless of medical therapy\n* The serum PSA should be ≤ 20 ng/ml within 120 days of registration\n* Study entry PSA must not be obtained during the following time frames: (1) 10-day period following prostate biopsy; (2) following initiation of ADT or anti-androgen therapy; (3) within 30 days after discontinuation of finasteride; (4) within 90 days after discontinuation of dutasteride; (5) within 5 days of a digital rectal examination\n* Ultrasound or MRI based volume estimation of prostate gland < 100 grams, regardless of cytoreduction with pharmacotherapy\n* Ability to undergo general anesthesia for <60 minutes\n* Ability to understand and the willingness to sign a written informed consent.\n* All men must agree to use adequate contraception (barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 90 days following completion of therapy.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 45 Years",
        "exclusion_criteria": "* Contraindications to UroLift System placement including:\n* Prostate volume >100 cc based on imaging-based estimation\n* Urethral conditions (e.g. urethral strictures and neoplams) that may prevent insertion of UroLift System delivery system into the bladder\n* Urinary incontinence due to incompetent sphincter\n* An active urinary tract infection\n* Current gross hematuria\n\nIn addition to the contraindications if there is a known allergy to nickel, titanium, or stainless steel these patients should be excluded\n\n* Prior transurethral resection of the prostate (TURP), median lobe manipulation, simple prostatectomy, or other ablative procedures for benign prostatic hyperplasia.\n* Foley / self-catheterization in the last 12 months.\n* Patients with all three intermediate risk factors (PSA >10 and ≤ 20, Gleason 7, clinical stage T2b-T2c) who ALSO have ≥50% of the number of their template biopsy cores positive for cancer are ineligible.\n* Prior pelvic radiotherapy, chemotherapy, or surgery for prostate cancer.\n* Current active androgen deprivation therapy",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* The serum PSA should be ≤ 20 ng/ml within 120 days of registration",
            "criterions": [
                {
                    "exact_snippets": "serum PSA should be ≤ 20 ng/ml",
                    "criterion": "serum PSA",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 20,
                                "unit": "ng/ml"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "within 120 days of registration",
                    "criterion": "serum PSA measurement timing",
                    "requirements": [
                        {
                            "requirement_type": "time from registration",
                            "expected_value": {
                                "operator": "<=",
                                "value": 120,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ultrasound or MRI based volume estimation of prostate gland < 100 grams, regardless of cytoreduction with pharmacotherapy",
            "criterions": [
                {
                    "exact_snippets": "Ultrasound or MRI based volume estimation of prostate gland < 100 grams",
                    "criterion": "prostate gland volume",
                    "requirements": [
                        {
                            "requirement_type": "measurement_method",
                            "expected_value": [
                                "Ultrasound",
                                "MRI"
                            ]
                        },
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 100,
                                "unit": "grams"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Baseline AUA symptom score ≥ 17 regardless of medical therapy",
            "criterions": [
                {
                    "exact_snippets": "Baseline AUA symptom score ≥ 17",
                    "criterion": "AUA symptom score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 17,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to undergo general anesthesia for <60 minutes",
            "criterions": [
                {
                    "exact_snippets": "Ability to undergo general anesthesia for <60 minutes",
                    "criterion": "ability to undergo general anesthesia",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 60,
                                "unit": "minutes"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age ≥ 45 years.",
            "criterions": [
                {
                    "exact_snippets": "Age ≥ 45 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 45,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be MALE",
            "criterions": [
                {
                    "exact_snippets": "Must be MALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to understand and the willingness to sign a written informed consent.",
            "criterions": [
                {
                    "exact_snippets": "Ability to understand",
                    "criterion": "cognitive ability",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* All men must agree to use adequate contraception (barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 90 days following completion of therapy.",
            "criterions": [
                {
                    "exact_snippets": "All men must agree to use adequate contraception (barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 90 days following completion of therapy.",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "method",
                            "expected_value": [
                                "barrier method of birth control",
                                "abstinence"
                            ]
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to study entry, for the duration of study participation, and for 90 days following completion of therapy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Study entry PSA must not be obtained during the following time frames: (1) 10-day period following prostate biopsy; (2) following initiation of ADT or anti-androgen therapy; (3) within 30 days after discontinuation of finasteride; (4) within 90 days after discontinuation of dutasteride; (5) within 5 days of a digital rectal examination",
            "criterions": [
                {
                    "exact_snippets": "Study entry PSA must not be obtained during the following time frames: (1) 10-day period following prostate biopsy",
                    "criterion": "PSA measurement timing after prostate biopsy",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "days after prostate biopsy"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Study entry PSA must not be obtained during the following time frames: ... (2) following initiation of ADT or anti-androgen therapy",
                    "criterion": "PSA measurement timing after initiation of ADT or anti-androgen therapy",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": "must not be obtained after initiation of ADT or anti-androgen therapy (exact time window not specified)"
                        }
                    ]
                },
                {
                    "exact_snippets": "Study entry PSA must not be obtained during the following time frames: ... (3) within 30 days after discontinuation of finasteride",
                    "criterion": "PSA measurement timing after discontinuation of finasteride",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": ">",
                                "value": 30,
                                "unit": "days after discontinuation of finasteride"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Study entry PSA must not be obtained during the following time frames: ... (4) within 90 days after discontinuation of dutasteride",
                    "criterion": "PSA measurement timing after discontinuation of dutasteride",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": ">",
                                "value": 90,
                                "unit": "days after discontinuation of dutasteride"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Study entry PSA must not be obtained during the following time frames: ... (5) within 5 days of a digital rectal examination",
                    "criterion": "PSA measurement timing after digital rectal examination",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "days after digital rectal examination"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) Performance status 0-1.",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) Performance status 0-1",
                    "criterion": "ECOG Performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologic confirmation of prostate cancer is required by biopsy performed within 18 months of registration.",
            "criterions": [
                {
                    "exact_snippets": "Histologic confirmation of prostate cancer is required",
                    "criterion": "prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "histologic confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "biopsy performed within 18 months of registration",
                    "criterion": "biopsy",
                    "requirements": [
                        {
                            "requirement_type": "performed_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 18,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* American Society of Anesthesia (ASA) physical status score of 1-3",
            "criterions": [
                {
                    "exact_snippets": "American Society of Anesthesia (ASA) physical status score of 1-3",
                    "criterion": "ASA physical status score",
                    "requirements": [
                        {
                            "requirement_type": "score range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 45 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 45 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 45,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* AJCC 8th edition clinical stage T1 (a, b, or c) or T2 (a, b, or c) adenocarcinoma of the prostate gland, Gleason 3+3 = 6 or 3+4 = 7, with no direct evidence of regional or distant metastases following appropriate staging studies. See Appendix I for details on AJCC 8th Edition staging criteria. T-staging may be assessed by multi-parametric imaging alone if digital rectal examination was deferred",
            "criterions": [
                {
                    "exact_snippets": "AJCC 8th edition clinical stage T1 (a, b, or c) or T2 (a, b, or c)",
                    "criterion": "AJCC clinical stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "T1a",
                                "T1b",
                                "T1c",
                                "T2a",
                                "T2b",
                                "T2c"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "adenocarcinoma of the prostate gland",
                    "criterion": "prostate gland adenocarcinoma",
                    "requirements": [
                        {
                            "requirement_type": "histology",
                            "expected_value": "adenocarcinoma"
                        },
                        {
                            "requirement_type": "primary_site",
                            "expected_value": "prostate gland"
                        }
                    ]
                },
                {
                    "exact_snippets": "Gleason 3+3 = 6 or 3+4 = 7",
                    "criterion": "Gleason score",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": [
                                "3+3=6",
                                "3+4=7"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "no direct evidence of regional or distant metastases following appropriate staging studies",
                    "criterion": "regional or distant metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Current gross hematuria",
            "criterions": [
                {
                    "exact_snippets": "Current gross hematuria",
                    "criterion": "gross hematuria",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* An active urinary tract infection",
            "criterions": [
                {
                    "exact_snippets": "An active urinary tract infection",
                    "criterion": "urinary tract infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current active androgen deprivation therapy",
            "criterions": [
                {
                    "exact_snippets": "Current active androgen deprivation therapy",
                    "criterion": "androgen deprivation therapy",
                    "requirements": [
                        {
                            "requirement_type": "current activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Foley / self-catheterization in the last 12 months.",
            "criterions": [
                {
                    "exact_snippets": "Foley / self-catheterization in the last 12 months",
                    "criterion": "Foley catheterization",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Foley / self-catheterization in the last 12 months",
                    "criterion": "self-catheterization",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "In addition to the contraindications if there is a known allergy to nickel, titanium, or stainless steel these patients should be excluded",
            "criterions": [
                {
                    "exact_snippets": "known allergy to nickel",
                    "criterion": "allergy to nickel",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known allergy to ... titanium",
                    "criterion": "allergy to titanium",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known allergy to ... stainless steel",
                    "criterion": "allergy to stainless steel",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior transurethral resection of the prostate (TURP), median lobe manipulation, simple prostatectomy, or other ablative procedures for benign prostatic hyperplasia.",
            "criterions": [
                {
                    "exact_snippets": "Prior transurethral resection of the prostate (TURP)",
                    "criterion": "transurethral resection of the prostate (TURP)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "median lobe manipulation",
                    "criterion": "median lobe manipulation",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "simple prostatectomy",
                    "criterion": "simple prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "other ablative procedures for benign prostatic hyperplasia",
                    "criterion": "ablative procedures for benign prostatic hyperplasia",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with all three intermediate risk factors (PSA >10 and ≤ 20, Gleason 7, clinical stage T2b-T2c) who ALSO have ≥50% of the number of their template biopsy cores positive for cancer are ineligible.",
            "criterions": [
                {
                    "exact_snippets": "PSA >10 and ≤ 20",
                    "criterion": "PSA",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 10,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 20,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Gleason 7",
                    "criterion": "Gleason score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "=",
                                "value": 7,
                                "unit": ""
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "clinical stage T2b-T2c",
                    "criterion": "clinical stage",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": [
                                "T2b",
                                "T2c"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "≥50% of the number of their template biopsy cores positive for cancer",
                    "criterion": "percentage of template biopsy cores positive for cancer",
                    "requirements": [
                        {
                            "requirement_type": "percentage",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Urinary incontinence due to incompetent sphincter",
            "criterions": [
                {
                    "exact_snippets": "Urinary incontinence due to incompetent sphincter",
                    "criterion": "urinary incontinence",
                    "requirements": [
                        {
                            "requirement_type": "cause",
                            "expected_value": "incompetent sphincter"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Contraindications to UroLift System placement including:",
            "criterions": [
                {
                    "exact_snippets": "Contraindications to UroLift System placement",
                    "criterion": "contraindications to UroLift System placement",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prostate volume >100 cc based on imaging-based estimation",
            "criterions": [
                {
                    "exact_snippets": "Prostate volume >100 cc based on imaging-based estimation",
                    "criterion": "prostate volume",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 100,
                                "unit": "cc"
                            }
                        },
                        {
                            "requirement_type": "assessment_method",
                            "expected_value": "imaging-based estimation"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Urethral conditions (e.g. urethral strictures and neoplams) that may prevent insertion of UroLift System delivery system into the bladder",
            "criterions": [
                {
                    "exact_snippets": "Urethral conditions (e.g. urethral strictures and neoplams) that may prevent insertion of UroLift System delivery system into the bladder",
                    "criterion": "urethral conditions",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "urethral strictures",
                                "urethral neoplasms"
                            ]
                        },
                        {
                            "requirement_type": "effect on procedure",
                            "expected_value": "may prevent insertion of UroLift System delivery system into the bladder"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior pelvic radiotherapy, chemotherapy, or surgery for prostate cancer.",
            "criterions": [
                {
                    "exact_snippets": "Prior pelvic radiotherapy",
                    "criterion": "pelvic radiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chemotherapy",
                    "criterion": "chemotherapy for prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "surgery for prostate cancer",
                    "criterion": "surgery for prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}